首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   459篇
  免费   43篇
  国内免费   1篇
林业   9篇
农学   5篇
基础科学   6篇
  50篇
综合类   57篇
农作物   8篇
水产渔业   23篇
畜牧兽医   285篇
园艺   2篇
植物保护   58篇
  2021年   6篇
  2020年   6篇
  2019年   5篇
  2018年   13篇
  2017年   9篇
  2016年   8篇
  2015年   12篇
  2014年   6篇
  2013年   12篇
  2012年   17篇
  2011年   24篇
  2010年   13篇
  2009年   21篇
  2008年   30篇
  2007年   40篇
  2006年   17篇
  2005年   29篇
  2004年   18篇
  2003年   16篇
  2002年   18篇
  2001年   9篇
  2000年   5篇
  1999年   5篇
  1998年   9篇
  1997年   9篇
  1996年   9篇
  1995年   12篇
  1994年   6篇
  1993年   7篇
  1992年   14篇
  1991年   3篇
  1990年   8篇
  1989年   3篇
  1988年   5篇
  1986年   2篇
  1983年   7篇
  1982年   3篇
  1981年   9篇
  1980年   2篇
  1979年   2篇
  1978年   4篇
  1977年   4篇
  1976年   6篇
  1975年   4篇
  1974年   2篇
  1972年   5篇
  1971年   6篇
  1970年   2篇
  1968年   5篇
  1967年   3篇
排序方式: 共有503条查询结果,搜索用时 31 毫秒
61.
62.
The metabolism of [14C]triadimefon, triadimenol, diclobutrazol, and the oxo-analogue of diclobutrazol by the basidiomycete fungi Coriolus versicolor and Rhizoctonia solani was studied. Reduction of >C = 0 to >CHOH (activation) was more important for triadimefon than oxo-diclobutrazol. Conversely, oxidation of >CHOH to >C = 0 (deactivation) occurred to a greater extent with diclobutrazol than triadimenol. Formation of primary alcohol metabolites, a possible detoxication route, occurred more with diclobutrazol and its oxo-analogue than with triadimefon and triadimenol. The implications of the reduction/oxidation processes and primary alcohol formation on fungitoxicity of the applied triazolymethane are discussed. The enantiomeric composition of metabolically produced triadimenol is discussed in relation to the in vitro activity of triadimefon supplied against each fungus.  相似文献   
63.
64.
Young adult heterozygous (carrier) female dogs with X-linked hereditary nephropathy (XLHN) have glomerular proteinuria but are otherwise healthy. Because data regarding dietary influences on the magnitude of proteinuria in dogs with spontaneous glomerular disease are not available, 12 such dogs were studied in a double crossover experiment intended to determine effects of altering dietary protein intake for up to 6 weeks. Dogs were blocked by urine protein : creatinine ratio (UPC) and randomly assigned to receive 2 diets: high protein (34.6% dry matter [DM], HP) or low protein (14.1% DM, LP) fed in HP-LP-HP or LP-HP-LP sequence. Food intake was measured daily, body weight (BW) was measured twice weekly, and UPC, plasma creatinine, blood urea nitrogen, phosphorus, albumin, and protein concentrations were measured at 2-week intervals. Nutrient digestibility was measured during the third treatment period. Diet had a significant effect (P < .0001) on all measured variables except plasma phosphorus (P > .5), but unintended differences in digestibility of protein and energy (P < or = .01) prevented assignment of the diet effect exclusively to protein. Proteinuria was greater (UPC 4.7 +/- 2.2 versus 1.8 +/- 1.1, P < .0001) when the HP diet was fed, but the LP diet did not maintain starting BW or plasma albumin concentration within the normal reference range. Diet greatly affects the magnitude of proteinuria in XLHN carrier females. Dietary protein restriction can reduce proteinuria in dogs with glomerular disease, but BW and blood protein concentrations may not be maintained if the restriction is too severe.  相似文献   
65.
Pharmacokinetic parameters of florfenicol were determined in 10 adult sheep (five wethers and five ewes) after a single 40 mg/kg intravenous (i.v.) dose, and three daily subcutaneous (s.c.) doses of 40 mg/kg of a commercial preparation (Nuflor((R))). The concentration of florfenicol in serum samples was assayed using a proprietary HPLC assay method, and pharmacokinetic parameters derived for individual animal data by each route using compartmental and noncompartmental approaches. Two animals (one male and one female) were excluded due to observed i.v. dosing problems, and a biexponential model was found to fit the i.v. data well for six of the other eight animals. Data from two males showed prolonged low concentrations of florfenicol in serum and were better fit by a three-compartment model. The mean +/- SD for the half-lives of the distribution and elimination phases for the six sheep best fit with a two-compartment model were 0.069 +/- 0.018 and 1.01 +/- 0.09 h respectively, and for the V(d(ss)) and clearances were 0.503 +/- 0.035 L/kg and 366 +/- 53 mL/h/kg respectively. The data collected during the s.c. multiple dose study were analyzed using noncompartmental methods only. The bioavailability (F%) after s.c. dosing was calculated in three ways to compare estimation methods as steady-state had not been reached and single dose s.c. data were not obtained past 24 h. Using the AUC(0--24) and AUC(0--> infinity ) from the first dose, the F% values averaged 27 and 40% respectively. Using the AUC(0--> infinity ) for all doses, the F% was 65%. Calculations of the mean time during which the serum concentration exceeded 0.5 and 1.0 microg/mL were 105 +/- 3.9 and 74.7 +/- 12.2 h respectively.  相似文献   
66.
OBJECTIVE: To radiographically evaluate the Zurich cementless total hip (ZCTH) cup and correlate lucency with clinical signs of implant instability, time since surgery, and implant generation, using zonal analysis. STUDY DESIGN: Retrospective study. ANIMALS: Client-owned dogs (n = 53). METHODS: Radiographs of dogs that had ZCTH arthroplasty (>1 year) were evaluated using zonal analysis, for lucency surrounding the cup-bone interface (number of zones, length, area). Dogs were examined for clinical signs of implant instability (lameness, hip pain). Lucency was correlated with lameness, time after surgery, and implant generation. RESULTS: Radiographs of 68 implants (18 generation I, 50 generation II) were evaluated. Eight dogs were lame (11.8%). Dogs with lameness were more likely to have lucency in > or =2 zones of analysis (per view), have >2 times the average curvilinear length of lucency, and have >4 times the average area of lucency surrounding the implant compared with non-lame dogs. A weak relationship was observed between time after surgery and implant generation; however, there was no relationship between time after surgery and lucency. CONCLUSIONS: Dogs with lameness after ZCTH arthroplasty were more likely to have lucency at the cup-bone interface. Lucency was better evaluated by radiographic projection than zonal analysis. Temporal progression of lucency was weakly correlated with implant generation. CLINICAL RELEVANCE: Dogs with lucency in > or =2 zones of analysis should be evaluated more frequently for clinical signs of implant loosening. Further investigation of serial radiographs after ZCTH arthroplasty is warranted.  相似文献   
67.
Goudey CA 《Science (New York, N.Y.)》2006,314(5807):1875-6; author reply 1875-6
  相似文献   
68.
Inbred laboratory mouse strains are highly divergent in their immune response patterns as a result of genetic mutations and polymorphisms. The generation of genetically engineered mice (GEM) has, in the past, used embryonic stem (ES) cells for gene targeting from various 129 substrains followed by backcrossing into more fecund mouse strains. Although common inbred mice are considered "immune competent," many have variations in their immune system-some of which have been described-that may affect the phenotype. Recognition of these immune variations among commonly used inbred mouse strains is essential for the accurate interpretation of expected phenotypes or those that may arise unexpectedly. In GEM developed to study specific components of the immune system, accurate evaluation of immune responses must take into consideration not only the gene of interest but also how the background strain and microbial milieu contribute to the manifestation of findings in these mice. This article discusses points to consider regarding immunological differences between the common inbred laboratory mouse strains, particularly in their use as background strains in GEM.  相似文献   
69.
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号